Weight Loss Reverses Adipose Senescence but Leaves Immune Memory Intact

Obesity affects over one billion people and drives type 2 diabetes, cardiovascular disease, and premature death largely through pathological remodeling of adipose tissue (AT). Despite extensive research, the precise molecular triggers and cellular phenotypes responsible for obese AT dysfunction — and its reversal by weight loss — have remained poorly defined, limiting therapeutic development.

To address this, investigators at Imperial College London constructed a spatially resolved single-nucleus RNA sequencing atlas comprising 171,247 cells from 70 individuals: 25 people with extreme obesity sampled before and after bariatric weight-loss surgery, and 24 healthy lean controls. The primary focus was abdominal subcutaneous AT, a depot closely linked to central obesity and adverse metabolic risk. These data were integrated with approximately 50,000 additional published nuclei and complemented by spatial transcriptomics to map cell states to specific tissue niches.

A central discovery was selective cellular senescence in metabolic cells (adipocytes), progenitor/precursor populations, and vascular cells in obese AT. Senescence was not uniform across all cell types but showed striking cell-type selectivity. Critically, weight loss potently reversed this senescent phenotype, identifying senescence reversal as a likely mechanism underlying the metabolic benefits of weight loss. The authors also defined gene regulatory networks and intercellular signaling circuits that may sustain a degenerative cycle of senescence, tissue injury, and metabolic dysfunction in obesity.

Weight loss reduced adipocyte hypertrophy and suppressed biomechanical constraint pathways — pathways activated when enlarged fat cells physically stress their microenvironment. This decompression appeared to unleash global metabolic flux and bioenergetic substrate cycling, providing a plausible mechanistic bridge between fat mass reduction and systemic improvements in insulin sensitivity and metabolic health.

In the immune compartment, weight loss repressed the obesity-driven infiltration of macrophages into AT. However, macrophage activation was not fully reversed: these cells remained in a primed inflammatory state post-weight loss. This incomplete immune reset may represent a maladaptive memory that predisposes individuals to weight regain and sustained or worsened metabolic dysfunction — a finding with significant clinical implications for long-term obesity management. The spatial mapping further revealed how distinct tissue niches collectively determine the injury and recovery landscape of AT, offering a high-resolution framework for future mechanistic and therapeutic investigation.